faces-image
faces-image
search icon
search icon

Buy Alluzience online at Faces, the ready-to-use liquid botulinum toxin type A from Galderma, supplied to registered UK aesthetic practitioners. Alluzience is licensed for the temporary improvement of moderate to severe glabellar lines, the vertical frown lines between the eyebrows, in adults under 65. It arrives pre-mixed, so there is no powder to reconstitute and no dilution step before treatment. Choose from single 125 unit vials or twin packs, and sign in to view trade pricing.

search icon
faces-image

Buy Alluzience Online for Aesthetic Professionals

For aesthetic practitioners looking to stock Alluzience through a verified professional supplier, Faces provides access to the complete range at competitive wholesale pricing with fast UK delivery. Alluzience is the first ready-to-use liquid botulinum toxin type A available in the UK, manufactured by Galderma and eliminating the need for reconstitution, saving valuable clinical time and removing the variability associated with powder dilution across every anti-wrinkle injection treatment session.

What Is Alluzience?

Alluzience is a prescription-only botulinum toxin type A supplied as a clear liquid at 200 Speywood units per ml. It was the first ready-to-use liquid toxin licensed in the UK, which removes the reconstitution step that powder toxins need. Its UK licence covers moderate to severe glabellar lines in adults under 65. It is not currently licensed in the UK for forehead lines or crow’s feet.

Alluzience vs Botox: Key Clinical Differences

Alluzience vs Botox comparisons highlight two distinct clinical differences. First, Alluzience is pre-mixed, removing reconstitution steps and eliminating diluent variability. Second, abobotulinumtoxinA has a broader diffusion profile than onabotulinumtoxinA, making Alluzience particularly suited to glabellar (frown line) treatments where broader, softer diffusion delivers natural-looking results.

Alluzience Dosage and Administration

Alluzience comes ready to use at a fixed strength of 200 Speywood units per ml, with 125 units in each 0.625 ml vial. The licensed dose for glabellar lines is 50 Speywood units in total, given as 10 units into each of five injection points. Because the solution is already mixed, there is no reconstitution step and no dilution to calculate. Speywood units are specific to this toxin and do not convert one to one with units of other brands, so always dose from the Alluzience SmPC. Treatments should be spaced at least three months apart.

Top Products in the Alluzience Range

  • Alluzience 2x125 Units Twin Pack: Pre-mixed ready-to-use liquid abobotulinumtoxinA twin vial pack for practitioners offering regular anti-wrinkle injection sessions requiring convenient, high-volume toxin supply.

  • Alluzience 1x125 Units Single Vial: A single pre-mixed liquid botulinum toxin vial, suited to clinics starting out with Alluzience or running lower-volume treatment programmes.

Clinical Guidance and Treatment Insights

Alluzience is trusted by thousands of practitioners across the UK who also rely on Faces as their booking and client management platform. Faces is free to join. Create your account to order Alluzience, manage client bookings, and showcase your treatments all from one platform. Sign in if you are already with us.

Buy Alluzience Online at Faces

Register with Faces today to access Alluzience at competitive wholesale pricing, with fast UK delivery and verified authentic stock trusted by practitioners nationwide.

Explore More Products Trusted by Thousands of Practitioners

Looking for complementary products? Faces also stocks trusted toxin brands used by practitioners across the UK, including Azzalure and Dysport, alongside dermal fillers and skin boosters for clinics looking to stock everything in one place. See what thousands of UK practitioners are already stocking on Faces.

Questions we get asked

Both are ready-to-use liquid toxins from Galderma, but they contain different toxins and have different licences. Alluzience (abobotulinumtoxinA) is licensed for glabellar lines only, with a recommended dose of 0.25 ml (50 Speywood units). Relfydess (relabotulinumtoxinA) is licensed for moderate to severe glabellar lines and lateral canthal lines (crow’s feet), alone or in combination. Its concentration is 10 units per 0.1 ml, with 50 units (0.5 ml) recommended for glabellar lines and 60 units (0.6 ml) for lateral canthal lines. Relfydess units are specific to that product and aren’t interchangeable with other botulinum toxins, so always follow each product’s own SmPC.

Most patients notice an effect within a few days; in clinical trials, the median time to onset reported by patients was 3 days. The full result is usually seen at around two weeks, which is the best time for a review appointment.

An effect has been shown for up to 6 months after injection, although duration varies between patients depending on muscle strength, metabolism, and treatment history. Set expectations at consultation, and remember that retreatment should be no more frequent than every 3 months.

The most common side effects are headache and injection-site reactions such as pain, redness, swelling or bruising, which usually resolve within a few days. Eyelid or brow ptosis can occur less commonly and can be minimised with accurate placement. It’s contraindicated where there’s infection at the injection site, or in patients with myasthenia gravis, Eaton-Lambert syndrome or ALS. Always warn patients about the rare risk of distant toxin spread, and refer to the SmPC for the full safety information.

Store Alluzience in the fridge at 2–8°C, away from light, until you treat, and check the expiry date when it arrives. Because it’s already a liquid, no diluent is needed, and each vial should be used for one patient in a single treatment session.

Alluzience prices depend on the pharmacy you order from and the pack size (single vial or twin pack). Log in or register with Faces to see current trade pricing. When comparing costs with powder toxins, factor in the time saved on reconstitution and the lower risk of wastage from dilution errors.

Yes. Alluzience is a prescription-only medicine. On Faces, prescriptions must be signed by a UK-registered healthcare professional (such as a doctor, dentist, nurse, pharmacist or qualified non-medical prescriber) who has carried out a consultation with the patient, and the products are for the named patient only and not for resale. If you’re not a prescriber, you can use Faces’ Find a Prescriber service.

In the UK, Alluzience is licensed for adult patients under 65 years with moderate to severe glabellar lines, and it isn’t recommended for patients under 18, as safety and efficacy haven’t been established in that age group. It should only be administered by a doctor or other healthcare practitioner with the appropriate qualifications. Practitioners should also hold suitable training and insurance for toxin treatments.